Reticuloendothelial system fc receptor function in rheumatoid arthritis

Area of Science:

• Immunology
• Rheumatology
• Pathophysiology

Background:

• Systemic lupus erythematosus (SLE) patients exhibit abnormal reticuloendothelial system (RES) IgG Fc receptor function linked to disease activity and immune complexes (IC).
• Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation and potential systemic manifestations.

Purpose of the Study:

• To investigate RES function, IC levels, and clinical/laboratory features in rheumatoid arthritis (RA) patients.
• To determine if RES dysfunction correlates with disease activity or IC levels in RA, contrasting findings in SLE.

Main Methods:

• Studied 43 RA patients, assessing RES function (clearance times), IC levels (Clq binding, Raji cell assays), clinical manifestations (articular index, extraarticular features), and laboratory markers (ESR).
• Compared RES function and its correlation with disease parameters to known patterns in SLE.

Main Results:

• 42/43 patients had abnormal articular index; 30 were seropositive; 31 had elevated ESR.
• Extraarticular manifestations included nodules, anemia, Sjögren's syndrome, vasculitis, and Felty's syndrome.
• 33 patients had detectable ICs; 30/43 showed prolonged RES clearance times (mean 106 min).
• Unlike SLE, RA RES clearance times did not correlate with IC levels or disease activity measures.

Conclusions:

• Rheumatoid arthritis patients frequently exhibit impaired RES immune clearance.
• Defective RES function in RA does not appear to be a significant factor in the pathogenesis of immunologic tissue damage.
• The role of RES dysfunction in RA pathogenesis differs from its role in SLE.